anti-RIP2 (RIP2) Antikörper

Bezeichnung:
anti-ROP Interactive Partner 2 Antikörper (RIP2)
Auf www.antikoerper-online.de finden Sie aktuell 25 ROP Interactive Partner 2 (RIP2) Antikörper von 5 unterschiedlichen Herstellern. Insgesamt sind aktuell 25 RIP2 Produkte verfügbar.
Synonyme:
2210420D18Rik, CARD3, CARDIAK, CCK, D4Bwg0615e, GIG30, RICK, RIP2
Alle Antikörper anzeigen Gen GeneID UniProt
RIP2 192656 P58801
RIP2 8767 O43353
RIP2    

Alle Spezies anzeigen

Weitere Synonyme anzeigen

Meistgesuchte Reaktivitäten zu anti-RIP2 (RIP2) Antikörper

Wählen Sie die Spezies und Applikation aus

anti-Mouse (Murine) RIP2 Antikörper:

anti-Human RIP2 Antikörper:

anti-Rat (Rattus) RIP2 Antikörper:

Alle verfügbaren anti-RIP2 Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Am meisten referenzierte anti-RIP2 Antikörper

  1. Human Polyclonal RIP2 Primary Antibody für IHC (fro), WB - ABIN2476367 : Inohara, del Peso, Koseki, Chen, Núñez: RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. in The Journal of biological chemistry 1998 (PubMed)
    Zeige alle 3 Referenzen für 2476367

Weitere Antikörper gegen RIP2 Interaktionspartner

Mouse (Murine) ROP Interactive Partner 2 (RIP2) Interaktionspartner

  1. this study reveals that LRRK2 (zeige LRRK2 Antikörper) is a new positive regulator of Rip2 (zeige ARHGDIG Antikörper) and promotes inflammatory cytokine induction through the Nod1 (zeige NOD1 Antikörper)/2-Rip2 (zeige ARHGDIG Antikörper) pathway.

  2. that Rip2 modifies VEGF-induced signalling and vascular permeability in myocardial ischaemia

  3. Bacterial polysaccharide-responsive miR (zeige MLXIP Antikörper)-150 and miR (zeige MLXIP Antikörper)-143 RIPK2 (zeige RIPK2 Antikörper) and TAK1 (zeige NR2C2 Antikörper) to suppress NOD2 (zeige NOD2 Antikörper)-induced immunomodulators.

  4. NOD2 (zeige NOD2 Antikörper) downregulates colonic inflammation by IRF4 (zeige IRF4 Antikörper)-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6 (zeige TRAF6 Antikörper).

  5. RIPK2 (zeige RIPK2 Antikörper) has a role in NOD signalling and in inflammatory cytokine production

  6. Rip2 (zeige ARHGDIG Antikörper)-deficient tumors showed enhanced epithelial-to-mesenchymal transition, with elevated expression of zeb1 (zeige ZEB1 Antikörper), zeb2 (zeige ZEB2 Antikörper), twist, and snail (zeige SNAI1 Antikörper) in the tumor microenvironment.

  7. data show that Nod1 (zeige NOD1 Antikörper), Nod2 (zeige NOD2 Antikörper) and Rip2 (zeige ARHGDIG Antikörper) are not required for local chemokine (zeige CCL1 Antikörper) production and neutrophil recruitment during CLP (zeige HAPLN1 Antikörper)-induced sepsis, and they reinforce the importance of MyD88 (zeige MYD88 Antikörper)-dependent signaling for initiation of a protective host response.

  8. Suggest that the Nod2 (zeige NOD2 Antikörper)-Rip2 (zeige ARHGDIG Antikörper) axis may contribute to the innate immune response of neutrophils against bacterial infection.

  9. Nod/Ripk2 (zeige RIPK2 Antikörper) signaling in dendritic cells activates IL-17A (zeige IL17A Antikörper)-secreting innate lymphoid cells and drives colitis in T-bet-/-.Rag2 (zeige RAG2 Antikörper)-/- (TRUC) mice.

  10. SMS (zeige SMS Antikörper) suppressed the activation of NF-kappaB (zeige NFKB1 Antikörper) and receptor interacting protein-2/caspase-1 (zeige CASP1 Antikörper).

Human ROP Interactive Partner 2 (RIP2) Interaktionspartner

  1. RIP2 (zeige ARHGEF28 Antikörper) kinase auto-phosphorylation is intimately coupled to dimerization.

  2. study provides structural and dynamic insights into the NOD1 (zeige NOD1 Antikörper)-RIP2 (zeige ARHGEF28 Antikörper) oligomer formation, which will be crucial in understanding the molecular basis of NOD1 (zeige NOD1 Antikörper)-mediated CARD-CARD interaction in higher and lower eukaryotes

  3. a new function of PAX5 (zeige PAX5 Antikörper) in regulating RIP1 (zeige UQCRFS1 Antikörper) and RIP2 (zeige ARHGEF28 Antikörper) activation, which is at least involved in chemotherapeutic drug resistance in B-lymphoproliferative disorders, is reported.

  4. this study reveals that LRRK2 (zeige LRRK2 Antikörper) is a new positive regulator of Rip2 (zeige ARHGEF28 Antikörper) and promotes inflammatory cytokine induction through the Nod1 (zeige NOD1 Antikörper)/2-Rip2 (zeige ARHGEF28 Antikörper) pathway.

  5. Together, the data demonstrate that the NOD2 (zeige NOD2 Antikörper)-RIP2 (zeige ARHGEF28 Antikörper) pathway is activated in murine and human visceral leishmaniasis and plays a role in shaping adaptive immunity toward a Th1 (zeige TH1L Antikörper) profile.

  6. RIP2 (zeige ARHGEF28 Antikörper) and RhoGDI (zeige ARHGDIA Antikörper) bind to p75(NTR (zeige NGFR Antikörper)) death domain at partially overlapping epitopes with over 100-fold difference in affinity, revealing the mechanism by which RIP2 (zeige ARHGEF28 Antikörper) recruitment displaces RhoGDI (zeige ARHGDIA Antikörper) upon ligand binding.

  7. that Rip2 modifies VEGF-induced signalling and vascular permeability in myocardial ischaemia

  8. Barettin has inhibitory activity against two protein kinases related to inflammation, namely the receptor-interacting serine/threonine kinase 2 (RIPK2 (zeige RIPK2 Antikörper)) and calcium/calmodulin-dependent protein kinase (zeige CAMK2 Antikörper) 1alpha (CAMK1alpha).

  9. RIPK1 (zeige RIPK1 Antikörper) and RIPK2 (zeige RIPK2 Antikörper) are targets of HIV-1 Protease activity during infection, and their inactivation may contribute to modulation of cell death and host defense pathways by HIV-1

  10. NOD2 (zeige NOD2 Antikörper) downregulates colonic inflammation by IRF4 (zeige IRF4 Antikörper)-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6 (zeige TRAF6 Antikörper).

RIP2 Antigen-Profil

Beschreibung des Gens

This gene encodes a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases. The encoded protein contains a C-terminal caspase activation and recruitment domain (CARD), and is a component of signaling complexes in both the innate and adaptive immune pathways. It is a potent activator of NF-kappaB and inducer of apoptosis in response to various stimuli.

Alternative names and synonyms associated with RIP2

  • receptor (TNFRSF)-interacting serine-threonine kinase 2 (Ripk2) Antikörper
  • receptor-interacting serine-threonine kinase 2 (RIPK2) Antikörper
  • 2210420D18Rik Antikörper
  • CARD3 Antikörper
  • CARDIAK Antikörper
  • CCK Antikörper
  • D4Bwg0615e Antikörper
  • GIG30 Antikörper
  • RICK Antikörper
  • RIP2 Antikörper

Bezeichner auf Proteinebene für RIP2

receptor-interacting serine/threonine-protein kinase 2 , tyrosine-protein kinase RIPK2 , CARD-carrying kinase , CARD-containing IL-1 beta ICE-kinase , CARD-containing interleukin-1 beta-converting enzyme (ICE)-associated kinase , RIP-2 , growth-inhibiting gene 30 , receptor-interacting protein (RIP)-like interacting caspase-like apoptosis regulatory protein (CLARP) kinase , receptor-interacting protein 2

GENE ID SPEZIES
192656 Mus musculus
8767 Homo sapiens
Ausgewählte Anbieter für anti-RIP2 (RIP2) Antikörper
Haben Sie etwas anderes gesucht?